Plasminogen Activator Inhibitor (PAI-1) - DiaPharma
JDB | Free Full-Text | Inhibition of SERPINE1 Function Attenuates Wound Closure in Response to Tissue Injury: A Role for PAI-1 in Re-Epithelialization and Granulation Tissue Formation
Plasminogen Activator Inhibitor-1 (PAI-1): Regulator of clotting
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease | NEJM
PAI-1 protein is a key molecular effector in the transition from normal to PTSD-like fear memory | Molecular Psychiatry
PAI-1 inhibitor: RS5614 | Renascience
Frontiers | Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk
Prothrombotic mechanisms of tumor cells. PAI-1: plasminogen activator... | Download Scientific Diagram
Plasminogen Activator Inhibitor-1 Signaling Pathway - Creative Diagnostics
PAI-1とは | ナノピア®PAI-1 | 積水メディカル株式会社
Plasminogen Activator Inhibitor-1 (PAI-1): Regulator of clotting
Schematic representation of PAI-1 action. PAI-1 not only inhibits local... | Download Scientific Diagram
The Case of a Late Bleeder Plasminogen Activator Inhibitor 1 Deficiency
Proposed roles of local and circulating plasminogen activator inhibitor... | Download Scientific Diagram
Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI) | Arteriosclerosis, Thrombosis, and Vascular Biology
Plasminogen activator inhibitor-1 and the kidney | American Journal of Physiology-Renal Physiology
Development of a plasminogen activator inhibitor (PAI-1) assay and comparison of plasma PAI-1 activity in hyperlipidemic/dyslipidemic dogs with either hyperadrenocorticism or diabetes mellitus, and healthy dogs - ScienceDirect
Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence | Arteriosclerosis, Thrombosis, and Vascular Biology
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome | Arteriosclerosis, Thrombosis, and Vascular Biology
JCI - Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity
Complete plasminogen activator inhibitor 1 deficiency: MedlinePlus Genetics
Frontiers | A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease
